Louisiana reaches deal for new hepatitis C treatment plan


Save Story
Leer en español

Estimated read time: Less than a minute

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.

BATON ROUGE, La. (AP) — For years, Louisiana offered hepatitis C treatment to only the most severe cases in its Medicaid program and prisons, unable to afford broader access to high-priced medications.

That will change in July, when the state rolls out a new treatment model it says can cure tens of thousands with the infectious disease.

Louisiana's health department announced a "subscription model" deal with Asegua Therapeutics on Wednesday. Louisiana will pay a flat fee for unlimited access to hepatitis C medication for five years, able to treat as many people as it can.

Health Secretary Rebekah Gee says Louisiana hopes to treat 31,000 of the estimated 39,000 Medicaid patients and prisoners with the disease. Louisiana will pay $58 million annually for the drug access.

The federal Medicaid agency announced last week that Washington has received approval to use a similar plan for its hepatitis C patients.

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Most recent U.S. stories

Related topics

U.S.
The Associated Press

    STAY IN THE KNOW

    Get informative articles and interesting stories delivered to your inbox weekly. Subscribe to the KSL.com Trending 5.
    By subscribing, you acknowledge and agree to KSL.com's Terms of Use and Privacy Policy.

    KSL Weather Forecast